Skip to content
10-Q

Quarterly Report

Fusion Pharmaceuticals Inc.

0000950170-23-059777

← back to feed
Filed
Nov 7, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 27, 2023 72.41M sh
Shares Diluted Q3 2023 · Sep 30, 2023 69.05M sh
Shares Diluted Q3 2023 · Sep 30, 2023 63.09M sh
Shares Diluted Q3 2023 · Sep 30, 2022 43.68M sh
Shares Diluted Q3 2023 · Sep 30, 2022 43.41M sh
Capex Q3 2023 · Sep 30, 2023 $2.41M
Capex Q3 2023 · Sep 30, 2022 $1.19M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$63.86M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$53.91M
Long Term Debt Q3 2023 · Sep 30, 2023 $34.63M
Long Term Debt Q3 2023 · Dec 31, 2022 $34.23M
Short Term Debt Q3 2023 · Sep 30, 2023 $35M
Short Term Investments Q3 2023 · Sep 30, 2023 $164.56M
Short Term Investments Q3 2023 · Dec 31, 2022 $127.01M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $26.79M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $43.86M
Stockholders Equity Q3 2023 · Sep 30, 2023 $188.47M
Stockholders Equity Q3 2023 · Jun 30, 2023 $202.96M
Stockholders Equity Q3 2023 · Mar 31, 2023 $200.83M
Stockholders Equity Q3 2023 · Dec 31, 2022 $162.22M
Stockholders Equity Q3 2023 · Sep 30, 2022 $183.14M
Stockholders Equity Q3 2023 · Jun 30, 2022 $198.91M
Stockholders Equity Q3 2023 · Mar 31, 2022 $215.43M
Stockholders Equity Q3 2023 · Dec 31, 2021 $231.46M
Current Liabilities Q3 2023 · Sep 30, 2023 $17.48M
Current Liabilities Q3 2023 · Dec 31, 2022 $15.07M
Total Liabilities Q3 2023 · Sep 30, 2023 $64.91M
Total Liabilities Q3 2023 · Dec 31, 2022 $56.84M
Current Assets Q3 2023 · Sep 30, 2023 $203.27M
Current Assets Q3 2023 · Dec 31, 2022 $179M
Total Assets Q3 2023 · Sep 30, 2023 $253.38M
Total Assets Q3 2023 · Dec 31, 2022 $219.06M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.25
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.06
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.55
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.45
Eps Basic Q3 2023 · Sep 30, 2023 −$0.25
Eps Basic Q3 2023 · Sep 30, 2023 −$1.06
Eps Basic Q3 2023 · Sep 30, 2022 −$0.55
Eps Basic Q3 2023 · Sep 30, 2022 −$1.45
Sga Expense Q3 2023 · Sep 30, 2023 $6.81M
Sga Expense Q3 2023 · Sep 30, 2023 $23.57M
Sga Expense Q3 2023 · Sep 30, 2022 $7.42M
Sga Expense Q3 2023 · Sep 30, 2022 $23.65M
Rd Expense Q3 2023 · Sep 30, 2023 $14.59M
Rd Expense Q3 2023 · Sep 30, 2023 $49.46M
Rd Expense Q3 2023 · Sep 30, 2022 $16.55M
Rd Expense Q3 2023 · Sep 30, 2022 $41.29M
Net Income Q3 2023 · Sep 30, 2023 −$17.25M
Net Income Q3 2023 · Sep 30, 2023 −$66.72M
Net Income Q3 2023 · Jun 30, 2023 −$25.18M
Net Income Q3 2023 · Mar 31, 2023 −$24.29M
Net Income Q3 2023 · Sep 30, 2022 −$24.01M
Net Income Q3 2023 · Sep 30, 2022 −$63M
Net Income Q3 2023 · Jun 30, 2022 −$19.07M
Net Income Q3 2023 · Mar 31, 2022 −$19.91M
Operating Income Q3 2023 · Sep 30, 2023 −$19.39M
Operating Income Q3 2023 · Sep 30, 2023 −$70.96M
Operating Income Q3 2023 · Sep 30, 2022 −$23.81M
Operating Income Q3 2023 · Sep 30, 2022 −$63.62M
Revenue Q3 2023 · Sep 30, 2023 $2.01M
Revenue Q3 2023 · Sep 30, 2023 $2.07M
Revenue Q3 2023 · Sep 30, 2022 $166K
Revenue Q3 2023 · Sep 30, 2022 $1.32M